Gbaguidi G Franck, Agellon Luis B
Canadian Institutes of Health Research Group in Molecular and Cell Biology of Lipids and Department of Biochemistry, 328 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta, Canada.
Biochim Biophys Acta. 2002 Jul 11;1583(2):229-36. doi: 10.1016/s1388-1981(02)00217-2.
Cholesterol 7alpha-hydroxylase (cyp7a) mediates cholesterol elimination in the liver by catalyzing the first and rate-limiting step in the conversion of cholesterol into bile acids. Peroxisome proliferator-activated receptor alpha (PPARalpha; NR1C1) and liver X receptor alpha (LXRalpha; NR1H3) are two nuclear receptors that stimulate the murine Cyp7a1 gene. Here we report that co-expression of PPARalpha and LXRalpha in hepatoma cells abolishes the stimulation of Cyp7a1 gene promoter in response to their respective agonists. PPARalpha and LXRalpha form an atypical heterodimer that binds to two directly adjacent hexameric sequences localized within overlapping PPARalpha and LXRalpha response elements (termed Site I), antagonizing the interaction of PPARalpha:retinoid X receptor alpha (RXRalpha) or RXRalpha:LXRalpha with the Cyp7a1 gene promoter. Mutations within either hexameric sequences that specifically abolished LXRalpha:PPARalpha heterodimer binding to the murine Cyp7a1 Site I also relieved promoter inhibition. The LXRalpha:PPARalpha heterodimer may be important in coordinating the expression of genes that encode proteins involved in metabolism of fats and cholesterol.
胆固醇7α-羟化酶(cyp7a)通过催化胆固醇转化为胆汁酸过程中的第一步也是限速步骤,介导肝脏中的胆固醇消除。过氧化物酶体增殖物激活受体α(PPARα;NR1C1)和肝脏X受体α(LXRα;NR1H3)是两种刺激小鼠Cyp7a1基因的核受体。在此我们报告,在肝癌细胞中PPARα和LXRα的共表达消除了对其各自激动剂的Cyp7a1基因启动子的刺激。PPARα和LXRα形成一种非典型异二聚体,该异二聚体与位于重叠的PPARα和LXRα反应元件(称为位点I)内的两个直接相邻的六聚体序列结合,拮抗PPARα:视黄酸X受体α(RXRα)或RXRα:LXRα与Cyp7a1基因启动子的相互作用。特异性消除LXRα:PPARα异二聚体与小鼠Cyp7a1位点I结合的任何一个六聚体序列内的突变也解除了启动子抑制。LXRα:PPARα异二聚体可能在协调编码参与脂肪和胆固醇代谢的蛋白质的基因表达中起重要作用。